Premier Asset Management LLC Galmed Pharmaceuticals Ltd. Transaction History

Premier Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$4.62 - $7.11 $359,916 - $553,897	-77,904 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$5.68 - $8.68 $442,494 - $676,206	77,904 New	77,904 $572,000
Q1 2019 May 15, 2019	SELL	$7.27 - $9.07 $537,616 - $670,726	-73,950 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$6.59 - $14.47 $487,330 - $1.07 Million	73,950 New	73,950 $505,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.53M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.